Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Gut Microbiome 100%
• Immunotherapy 60%
• Microbiome 40%
• Clinical Trial 20%
• Nodular Melanoma 20%
• Treatment Response 20%
• Epithelioma 20%
• Patient Experience 20%
• Fecal Microbiota Transplantation 20%

Immunology and Microbiology

• Immunotherapy 100%
• Gut Microbiome 100%
• Microbiome 66%
• Preclinical Study 33%
• Feces microflora 33%

Keyphrases

• Live Biotherapeutics 20%
• Lung Microbiome 20%
• Response to Immunotherapy 20%